Stock listing
Crescita Therapeutics, Inc.
Selected listing: CTX · NEO · CAD · CA
Crescita Therapeutics, Inc. (Cboe Canada: CTX), Health Technology. Latest release Jun 3, 2026: Crescita Therapeutics Inc. Announces Closing of Arrangement.
- Ticker
- Cboe Canada: CTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Cboe Canada
- Currency
- CAD
About Crescita Therapeutics, Inc.
The company focuses on developing and commercializing innovative prescription and over-the-counter products in the dermatology sector. Crescita aims to enhance patient care through its advanced therapeutic solutions.
Latest news from Crescita Therapeutics, Inc.
Crescita Therapeutics Inc. Announces Closing of Arrangement
June 3, 2026
Crescita Therapeutics Inc. Announces Final Consideration Payable to Shareholders Pursuant to Arrangement with ClinActiv
June 1, 2026
Crescita Therapeutics Inc. Obtains Final Order Approving Plan of Arrangement
May 20, 2026
Crescita Obtains Shareholder Approval To Be Acquired By ClinActiv Holdings
May 14, 2026
Crescita Reports First Quarter 2026 Results
May 11, 2026
Research Crescita Therapeutics, Inc.
Crescita Therapeutics, Inc. company profile
View the public company page for Crescita Therapeutics, Inc. on 6ix.
Crescita Therapeutics, Inc. news
Read company news and market updates connected to Crescita Therapeutics, Inc..
Crescita Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Crescita Therapeutics, Inc..